Template:SubstanceBox/Adrafinil: Difference between revisions
>BronzeManul m Replaced skeletal structure image with standardised svg image. |
>Blackhole added class membership information |
||
(4 intermediate revisions by 3 users not shown) | |||
Line 11: | Line 11: | ||
|ModuleStructure=true | |ModuleStructure=true | ||
|ModuleNomenclature=true | |ModuleNomenclature=true | ||
|ModuleClassMembership=true | |||
|ModuleROA=true | |ModuleROA=true | ||
Line 39: | Line 40: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=Adrafinil, Olmifon | |NameCommon=[[common name::Adrafinil]], [[common name::Olmifon]] | ||
|NameSubstitution=Adrafinil | |NameSubstitution=Adrafinil | ||
|NameSystematic=(±)-2-Benzhydrylsulfinylethanehydroxamic acid | |NameSystematic=(±)-2-Benzhydrylsulfinylethanehydroxamic acid | ||
<!-- Class Membership --> | |||
|EffectClass=[[psychoactive class::Stimulant]] / [[psychoactive class::Eugeroic]] | |||
|ChemicalClass=[[chemical class::Benzhydryl]] | |||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
Line 49: | Line 54: | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose::100]] | |OralROA_Threshold=[[Oral threshold dose::100]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::150]] - [[Oral max light dose::250]] mg | |OralROA_Light=[[Oral min light dose::150]] - [[Oral max light dose::250]] mg | ||
|OralROA_Common=[[Oral min common dose::250]] - [[Oral max common dose::400]] mg | |OralROA_Common=[[Oral min common dose::250]] - [[Oral max common dose::400]] mg |